Literature DB >> 23807151

Diagnostic odyssey of patients with myotonic dystrophy.

James E Hilbert1, Tetsuo Ashizawa, John W Day, Elizabeth A Luebbe, William B Martens, Michael P McDermott, Rabi Tawil, Charles A Thornton, Richard T Moxley.   

Abstract

The onset and symptoms of the myotonic dystrophies are diverse, complicating their diagnoses and limiting a comprehensive approach to their clinical care. This report analyzes the diagnostic delay (time from onset of first symptom to diagnosis) in a large sample of myotonic dystrophy (DM) patients enrolled in the US National Registry [679 DM type 1 (DM1) and 135 DM type 2 (DM2) patients]. Age of onset averaged 34.0 ± 14.1 years in DM2 patients compared to 26.1 ± 13.2 years in DM1 (p < 0.0001). The most common initial symptom in DM2 patients was leg weakness (32.6 %) compared to grip myotonia in DM1 (38.3 %). Pain was reported as the first symptom in 11.1 % of DM2 and 3.0 % of DM1 patients (p < 0.0001). Reaching the correct diagnosis in DM2 took 14 years on average (double the time compared to DM1) and a significantly higher percentage of patients underwent extended workup including electromyography, muscle biopsies, and finally genetic testing. DM patients who were index cases experienced similar diagnostic delays to non-index cases of DM. Further evaluation of how to shorten these diagnostic delays and limit their impact on burdens of disease, family planning, and symptom management is needed.

Entities:  

Mesh:

Year:  2013        PMID: 23807151      PMCID: PMC4162528          DOI: 10.1007/s00415-013-6993-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  Anesthetic and surgical complications in 219 cases of myotonic dystrophy.

Authors:  J Mathieu; P Allard; G Gobeil; M Girard; M De Braekeleer; P Bégin
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

Review 2.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

3.  Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.

Authors:  J W Day; K Ricker; J F Jacobsen; L J Rasmussen; K A Dick; W Kress; C Schneider; M C Koch; G J Beilman; A R Harrison; J C Dalton; L P W Ranum
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

4.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

5.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

6.  Genetic mapping of a second myotonic dystrophy locus.

Authors:  L P Ranum; P F Rasmussen; K A Benzow; M D Koob; J W Day
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

7.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Authors:  G Meola; V Sansone; D Perani; S Scarone; S Cappa; C Dragoni; E Cattaneo; M Cotelli; C Gobbo; F Fazio; G Siciliano; M Mancuso; E Vitelli; S Zhang; R Krahe; R T Moxley
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

8.  Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.

Authors:  K Ricker; M C Koch; F Lehmann-Horn; D Pongratz; M Otto; R Heine; R T Moxley
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

9.  Myotonic dystrophy with no trinucleotide repeat expansion.

Authors:  C A Thornton; R C Griggs; R T Moxley
Journal:  Ann Neurol       Date:  1994-03       Impact factor: 10.422

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  28 in total

1.  Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.

Authors:  Federica Montagnese; Stefania Mondello; Stephan Wenninger; Wolfram Kress; Benedikt Schoser
Journal:  J Neurol       Date:  2017-10-30       Impact factor: 4.849

2.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

Review 3.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

4.  Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.

Authors:  Stojan Peric; Ruzica Maksimovic; Bojan Banko; Milica Durdic; Bogdan Bjelica; Ivo Bozovic; Yunus Balcik; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2017-07-29       Impact factor: 4.849

5.  Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome.

Authors:  Tomasz Zemojtel; Sebastian Köhler; Luisa Mackenroth; Marten Jäger; Jochen Hecht; Peter Krawitz; Luitgard Graul-Neumann; Sandra Doelken; Nadja Ehmke; Malte Spielmann; Nancy Christine Oien; Michal R Schweiger; Ulrike Krüger; Götz Frommer; Björn Fischer; Uwe Kornak; Ricarda Flöttmann; Amin Ardeshirdavani; Yves Moreau; Suzanna E Lewis; Melissa Haendel; Damian Smedley; Denise Horn; Stefan Mundlos; Peter N Robinson
Journal:  Sci Transl Med       Date:  2014-09-03       Impact factor: 17.956

6.  Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

Authors:  A F Best; J E Hilbert; L Wood; W B Martens; N Nikolenko; C Marini-Bettolo; H Lochmüller; P S Rosenberg; R T Moxley; M H Greene; S M Gadalla
Journal:  Eur J Neurol       Date:  2018-09-16       Impact factor: 6.089

Review 7.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

8.  Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients.

Authors:  C Papadopoulos; K Kekou; S Xirou; S Kitsiou-Tzeli; E Kararizou; G K Papadimas
Journal:  Eye (Lond)       Date:  2017-12-08       Impact factor: 3.775

Review 9.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 10.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.